Sign in
Technology
Cannabis
Health Care
Energy
Metals
About
Contact Us
Advertising
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Journal Transcript
Technology
Cannabis
Health Care
Energy
Metals
About
Contact Us
Advertising
Disclaimer
Home
Tags
NASDAQ:GILD
Tag: NASDAQ:GILD
Business
Gilead Sciences, Inc. (NASDAQ:GILD) Halts Zydelig Trials Following EMA Review
Steve Kanaval
-
March 16, 2016
0
Business
Gilead Sciences, Inc. (NASDAQ:GILD)’s Zydelig Faces Safety Review From European Medicines...
Miles Sandford
-
March 15, 2016
0
Business
Gilead Sciences, Inc. (NASDAQ:GILD)’s Zydelig Comes Under Review from EMA
Miles Sandford
-
March 14, 2016
0
Business
Gilead Sciences, Inc. (NASDAQ:GILD) To Face Merck In A California Courtroom...
Vinita Bansal
-
March 10, 2016
0
Business
Merck Asks For $3 Billion In Royalties From Gilead Sciences, Inc....
Miles Sandford
-
March 8, 2016
0
Science
Gilead Sciences, Inc. (NASDAQ:GILD)’s HIV-1 Infection Treatment Gets U.S. FDA Approval
David Riley
-
March 3, 2016
0
1
...
3
4
5
Page 4 of 5
